Companies get U.S. FDA warning letters over diabetes medicines

07/23/2013 | Reuters

The U.S. FDA has warned 15 domestic and international companies to stop selling 20 drugs that it says make false diabetes claims. Some of the drugs are said to be natural products while containing active pharmaceutical ingredients. Others are prescription drugs sold without a prescription, and still others falsely claim to alleviate symptoms, the agency said. FDA compliance officer Howard Sklamberg said that health care fraud with diabetes treatments is a particularly large problem.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL